PMV Pharmaceuticals, Inc
Price
FilingsNewest: 8-K, Director or officer changeOct 5 →InsidersNo open-market buys. 2 insiders sold $1.5M in 1 sale, with no 10b5-1 plan named.→HoldersBML 10.0%Tang 7.9%Sio 4.9%→Financing →PeersClosest companies: TYRA, PRLD, BDTX→
From the filings
Figures
- Net income
- −$75.2Mlast 12 months
- Operating cash flow
- −$75.0Mlast 12 months
- Cash and equivalents
- $12.5Mat the last balance sheet
- Shares outstanding
- 53.5M shareson issue